Rami S Komrokji (Rami Komrokji)

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 88

Top Topics

Acute Myeloid Leukemia

Metastatic Renal Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, Ruben A Mesa, Alessandro Maria Maria Vannucchi, Rami S Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam J Mead, Jason Gotlib, Shelonitda Rose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne M Palmer, Kelly McCaul, Vincent Ribrag, Francesco Passamonti
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis. Blood advances 8 (17) (2024)
Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery 5 (4) (2024)
Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery 5 (4) (2024)
Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, Nico Gagelmann, Carmelo Gurnari, Somedeb Ball, Juan Carlos Caballero-Berrocal, Luca Lanino, Saverio D'Amico, Marta Spreafico, Giulia Maggioni, Erica Travaglino, Elisabetta Sauta, Manja Meggendorfer, Lin-Pierre Zhao, Alessia Campagna, null null, Victor Savevski, Armando Santoro, Najla Al Ali, David A Sallman, Francisco Solé, Guillermo Garcia Manero, Ulrich Germing, Nicolaus Kröger, Shahram Kordasti, Valeria Santini, Guillermo F Sanz, Wolfgang Kern, Uwe Platzbecker, Maria Diez Campelo, Jaroslaw P Maciejewski, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Amer M Zeidan, Gastone C Castellani, Rami S Komrokji, Francesca Ieva, Matteo Giovanni Della Porta, null null
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Aaron T Gerds, Claire Harrison, Jean-Jacques Kiladjian, Ruben A Mesa, Alessandro Maria Maria Vannucchi, Rami S Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam J Mead, Jason Gotlib, Shelonitda Rose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne M Palmer, Kelly McCaul, Vincent Ribrag, Francesco Passamonti
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis. Blood advances 8 (17) (2024)
Andrew T Kuykendall, Somedeb Ball, Barbara Mora, Qianxing Mo, Najla Al Ali, Margherita Maffioli, Giuseppe Auteri, Camilla Mazzoni, Giuseppe Alberto Maria Palumbo, Andrea Duminuco, Anna Longo, Elena Maria Elli, Francesco Passamonti, Francesca Palandri, Rami S Komrokji
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib. JCO precision oncology 8 (2024)
Elena Crisà, Elvira Mora, Ulrich Germing, Cecile Bally, Maria Diez Campelo, Mikko Myllymäki, Martin Jädersten, Rami S Komrokji, Uwe Platzbecker, Detlef Haase, Wolf-Karsten Hofmann, Najla H Al Ali, Daniela Barraco, Juan José Bargay, Teresa Bernal, Felix López Cadenas, Anna Calvisi, Isabella Capodanno, Marco Cerrano, Rosanna Ciancia, Monica Crugnola, Andrea Kündgen, Carlo Finelli, Claudio Fozza, Chiara Frairia, Ebeling Freja, Christina Ganster, Anne-Sophie Kubasch, Maria Jose Jimenez, Roberto Latagliata, Francisca Hernandez Mohedo, Antonieta Molero, Miriam Vara Pampliega, Clara Aparicio Perez, Giuseppe Pietrantuono, Antonella Poloni, Helena Pomares, Valle Recasens, Axel Rüfer, Alessio Signori, Eva Hellström Lindberg, Pierre Fenaux, Guillermo F Sanz, Valeria Santini
Transfusion independence after lenalidomide discontinuation in patients with del(5q) myelodysplastic neoplasm: a HARMONY Alliance study. Leukemia (2024)
Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra Sweet, Rami S Komrokji, Jeffrey Lancet
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML. Blood advances 8 (5) (2024)
Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery 5 (4) (2024)
Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery (2024)
Andrew T Kuykendall, Somedeb Ball, Barbara Mora, Qianxing Mo, Najla Al Ali, Margherita Maffioli, Giuseppe Auteri, Camilla Mazzoni, Giuseppe Alberto Maria Palumbo, Andrea Duminuco, Anna Longo, Elena Maria Elli, Francesco Passamonti, Francesca Palandri, Rami S Komrokji
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib. JCO precision oncology 8 (2024)
Zhuoer Xie, Rami S Komrokji, Najla Al-Ali, Alexandra Regelson, Susan Geyer, Anand Ashwin Patel, Caner Saygin, Amer M Zeidan, Jan Philipp Bewersdorf, Lourdes M Mendez, Ashwin Kishtagari, Joshua F Zeidner, Catherine C Coombs, Yazan F Madanat, Stephen S Chung, Talha Badar, James M Foran, Pinkal Desai, Charlton Tsai, Elizabeth A Griffiths, Monzr M Al Malki, Idoroenyi Amanam, Catherine E Lai, H Joachim Deeg, Lionel Ades, Cecilia Arana-Yi, Afaf E G Osman, Shira Naomi Dinner, Yasmin M Abaza, Justin Taylor, Namrata S Chandhok, Deborah Soong, Andrew M Brunner, Hetty E Carraway, Abhay Singh, Chiara Elena, Jacqueline Ferrari, Anna Galli, Sara Pozzi, Eric Padron, Mirinal S Patnaik, Luca Malcovati, Michael R Savona, Aref A Al-Kali
Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence. Blood (2024)
Aaron T Gerds, Claire N Harrison, Jean-Jacques Kiladjian, Ruben A Mesa, Alessandro Maria Maria Vannucchi, Rami S Komrokji, Prithviraj Bose, Marina Kremyanskaya, Adam Mead, Jason Gotlib, Shelonitda Rose, Fabian Sanabria, Niloufar Marsousi, Ana Carolina Giuseppi, Huijing Jiang, Jeanne M Palmer, Kelly McCaul, Vincent Ribrag, Francesco Passamonti
Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis. Blood advances (2024)
Onyee Chan, Najla H Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad O Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison R Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra L Sweet, Rami S Komrokji, Jeffrey E Lancet
Mutations Highly Specific for Secondary AML are Associated with Poor Outcomes in ELN Favorable Risk NPM1-mutated AML. Blood advances (2024)
Maria Julia Montoro, Laura Palomo, Claudia Haferlach, Pamela Acha, Onyee Chan, Víctor Navarro, Yasuo Kubota, Felicitas Isabel Schulz, Manja Meggendorfer, Robert Briski, Najla Al-Ali, Blanca Xicoy, Felix Lopez, Francesc Bosch, Teresa González, Lea Naomi Eder, Andrés Jerez, Yu-Hung Hung Wang, Alessia Campagna, Valeria Santini, Teresa Bernal Del Castillo, Esperanza Such, Hwei-Fang Tien, Nicolás Díaz Varela, Uwe Platzbecker, Detlef Thomas Haase, Maria Diez Campelo, Matteo Giovanni Della Porta, Guillermo Garcia-Manero, Daniel Howard Wiseman, Ulrich Germing, Jaroslaw P Maciejewski, Rami S Komrokji, Francisco Solé, Torsten Haferlach, David Valcárcel
Influence of TP53 Gene Mutations and its Allelic Status in Myelodysplastic Syndromes with Isolated 5q Deletion. Blood (2024)
Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seongseok Yun, Chetasi Talati, Andrew T Kuykendall, Eric Padron, Alison Walker, Gail J Roboz, Pinkal Desai, David A Sallman, Kendra Sweet, Rami S Komrokji, Jeffrey Lancet
Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML. Blood advances 8 (5) (2024)
Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, Nico Gagelmann, Carmelo Gurnari, Somedeb Ball, Juan Carlos Caballero-Berrocal, Luca Lanino, Saverio D'Amico, Marta Spreafico, Giulia Maggioni, Erica Travaglino, Elisabetta Sauta, Manja Meggendorfer, Lin-Pierre Zhao, Alessia Campagna, null null, Victor Savevski, Armando Santoro, Najla Al Ali, David A Sallman, Francisco Solé, Guillermo Garcia Manero, Ulrich Germing, Nicolaus Kröger, Shahram Kordasti, Valeria Santini, Guillermo F Sanz, Wolfgang Kern, Uwe Platzbecker, Maria Diez Campelo, Jaroslaw P Maciejewski, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Amer M Zeidan, Gastone C Castellani, Rami S Komrokji, Francesca Ieva, Matteo Giovanni Della Porta, null null
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, Nico Gagelmann, Carmelo Gurnari, Somedeb Ball, Juan Carlos Caballero-Berrocal, Luca Lanino, Saverio D'Amico, Marta Spreafico, Giulia Maggioni, Erica Travaglino, Elisabetta Sauta, Manja Meggendorfer, Lin-Pierre Zhao, Alessia Campagna, null null, Victor Savevski, Armando Santoro, Najla Al Ali, David A Sallman, Francisco Solé, Guillermo Garcia Manero, Ulrich Germing, Nicolaus Kröger, Shahram Kordasti, Valeria Santini, Guillermo F Sanz, Wolfgang Kern, Uwe Platzbecker, Maria Diez Campelo, Jaroslaw P Maciejewski, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Amer M Zeidan, Gastone C Castellani, Rami S Komrokji, Francesca Ieva, Matteo Giovanni Della Porta, null null
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery 5 (4) (2024)
Andrew T Kuykendall, Somedeb Ball, Barbara Mora, Qianxing Mo, Najla Al Ali, Margherita Maffioli, Giuseppe Auteri, Camilla Mazzoni, Giuseppe Alberto Maria Palumbo, Andrea Duminuco, Anna Longo, Elena Maria Elli, Francesco Passamonti, Francesca Palandri, Rami S Komrokji
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib. JCO precision oncology 8 (2024)
Cristina Astrid Tentori, Caterina Gregorio, Marie Robin, Nico Gagelmann, Carmelo Gurnari, Somedeb Ball, Juan Carlos Caballero-Berrocal, Luca Lanino, Saverio D'Amico, Marta Spreafico, Giulia Maggioni, Erica Travaglino, Elisabetta Sauta, Manja Meggendorfer, Lin-Pierre Zhao, Alessia Campagna, null null, Victor Savevski, Armando Santoro, Najla Al Ali, David A Sallman, Francisco Solé, Guillermo Garcia Manero, Ulrich Germing, Nicolaus Kröger, Shahram Kordasti, Valeria Santini, Guillermo F Sanz, Wolfgang Kern, Uwe Platzbecker, Maria Diez Campelo, Jaroslaw P Maciejewski, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Amer M Zeidan, Gastone C Castellani, Rami S Komrokji, Francesca Ieva, Matteo Giovanni Della Porta
Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Nicole D Vincelette, Xiaoqing Yu, Andrew T Kuykendall, Jungwon Moon, Siyuan Su, Chia-Ho Cheng, Rinzine Sammut, Tiffany N Razabdouski, Hai Vu Nguyen, Erika A Eksioglu, Onyee Chan, Najla Al Ali, Parth C Patel, Dae Hyun Lee, Shima Nakanishi, Renan B Ferreira, Elizabeth Hyjek, Qianxing Mo, Suzanne Cory, Harshani R Lawrence, Ling Zhang, Daniel J Murphy, Rami S Komrokji, Daesung Lee, Scott H Kaufmann, John L Cleveland, Seongseok Yun
Trisomy 8 Defines a Distinct Subtype of Myeloproliferative Neoplasms Driven by the MYC-Alarmin Axis. Blood cancer discovery (2024)
Caterina Gregorio, Marta Spreafico, Saverio D'Amico, Elisabetta Sauta, Gianluca Asti, Luca Lanino, Cristina Astrid Tentori, Uwe Platzbecker, Torsten Haferlach, Maria Diez Campelo, Pierre Fenaux, Rami S Komrokji, Matteo Giovanni Della Porta, Francesca Ieva
Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation. JCO clinical cancer informatics 8 (2024)
Mikkael A Sekeres, Nina Kim, Amy E DeZern, Kelly J Norsworthy, Jacqueline S Garcia, R Angelo de Claro, Marc R Theoret, Emily Y Jen, Lori A Ehrlich, Amer M Zeidan, Rami S Komrokji
Considerations for Drug Development in Myelodysplastic Syndromes. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Parth C Patel, Somedeb Ball, Akriti Gupta Jain, Chen Wang, Mohammad O Hussaini, Luis E Aguirre, Onyee Chan, Seongseok Yun, Andrew T Kuykendall, Eric Padron, Kendra L Sweet, Jeffrey E Lancet, Rami S Komrokji, David A Sallman
Drivers of deep molecular response and long-term outcomes in patients with core binding factor acute myeloid leukemia. American journal of hematology (2023)
Gregory A Abel, Donnie Hebert, Cecilia Lee, Dana E Rollison, Nancy Gillis, Rami S Komrokji, James M Foran, Jane Jijun Liu, Tareq Al Baghdadi, H Joachim Deeg, Steven D Gore, Wael Saber, Steffanie H Wilson, Michael C Otterstatter, Jason Thompson, Christine Borchert, Eric Padron, Amy DeZern, David Cella, Mikkael A Sekeres
Health-Related Quality of Life and Vulnerability among People with Myelodysplastic Syndromes: A US National Study. Blood advances (2023)
Amer M Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf, Maximilian Stahl, Lionel Ades, Uma Borate, David T Bowen, Rena J Buckstein, Andrew M Brunner, Hetty E Carraway, Naval G Daver, Maria Diez Campelo, Theo M de Witte, Amy E DeZern, Fabio Efficace, Guillermo Garcia-Manero, Jacqueline S Garcia, Ulrich Germing, Aristoteles Giagounidis, Elizabeth A Griffiths, Robert P Hasserjian, Eva Hellström-Lindberg, Marcelo C Iastrebner, Rami S Komrokji, Austin G Kulasekararaj, Luca Malcovati, Yasushi Miyazaki, Olatoyosi Odenike, Valeria Santini, Guillermo F Sanz, Phillip Scheinberg, Reinhard Stauder, Arjan A Van de Loosdrecht, Andrew H Wei, Mikkael A Sekeres, Pierre Fenaux
Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes. Blood (2023)
Amer M Zeidan, Uwe Platzbecker, Jan Philipp Bewersdorf, Maximilian Stahl, Lionel Ades, Uma Borate, David T Bowen, Rena J Buckstein, Andrew M Brunner, Hetty E Carraway, Naval G Daver, Maria Diez Campelo, Theo M de Witte, Amy E DeZern, Fabio Efficace, Guillermo Garcia-Manero, Jacqueline S Garcia, Ulrich Germing, Aristoteles Giagounidis, Elizabeth A Griffiths, Robert P Hasserjian, Eva Hellström-Lindberg, Marcelo C Iastrebner, Rami S Komrokji, Austin G Kulasekararaj, Luca Malcovati, Yasushi Miyazaki, Olatoyosi Odenike, Valeria Santini, Guillermo F Sanz, Phillip Scheinberg, Reinhard Stauder, Arjan A Van de Loosdrecht, Andrew H Wei, Mikkael A Sekeres, Pierre Fenaux
Consensus proposal for revised International Working Group response criteria for higher risk myelodysplastic syndromes. Blood (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): a Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology (2023)
Naval G Daver, Paresh Vyas, Suman Kambhampati, Monzr M Al Malki, Richard A Larson, Adam S Asch, Gabriel Mannis, Wanxing Chai-Ho, Tiffany N Tanaka, Terrence J Bradley, Deepa Jeyakumar, Eunice S Wang, Kendra Sweet, Hagop M Kantarjian, Guillermo Garcia Manero, Rami S Komrokji, Guan Xing, Giridharan Ramsingh, Camille Renard, Joshua F Zeidner, David A Sallman
Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Rami S Komrokji, Luis E Aguirre, Najla Al-Ali, Onyee Chan, Zhuoer Xie, Andrew T Kuykendall, Kendra L Sweet, Jeffrey E Lancet, Eric Padron, David A Sallman
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes. Blood advances (2023)
John O Mascarenhas, Anna Rita Migliaccio, Heidi E Kosiorek, Rupali Bhave, Jeanne M Palmer, Andrew T Kuykendall, Ruben A Mesa, Raajit K Rampal, Aaron T Gerds, Abdulraheem Yacoub, Kristen Pettit, Moshe Talpaz, Rami S Komrokji, Marina Kremyanskaya, Agapito Gonzalez, Frank Fabris, Kathryn Johnson, Mikaela Dougherty, Erin M McGovern, Juan Esteban Arango Ossa, Dylan Domenico, Noushin Farnoud, Rona Singer Weinberg, Amy Kong, Vesna Najfeld, Alessandro Maria Maria Vannucchi, Francesca Arciprete, Maria Zingariello, Mario Falchi, Mohamed E Salama, Carolyn Mead-Harvey, Amylou C Dueck, Lilian Varricchio, Ronald Hoffman
A Phase 1b trial of AVID200, a TGFβ 1/3 trap, in patients with myelofibrosis. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ayalew Tefferi, Farah Fleti, Onyee Chan, Najla H Al Ali, Aref A Al-Kali, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Mithun Vinod Shah, Devendra K Hiwase, Eric Padron, David A Sallman, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q). British journal of haematology (2023)
Amy E DeZern, Johannes B Goll, R Coleman Lindsley, Rafael Bejar, Steffanie H Wilson, Donnie Hebert, H Joachim Deeg, Ling Zhang, Steven D Gore, Tareq Al Baghdadi, Jaroslaw P Maciejewski, Jane Jijun Liu, Eric Padron, Rami S Komrokji, Wael Saber, Gregory A Abel, Steven H Kroft, Alexandra M Harrington, Somnath Datta, Harrison H Vaughn Reed, Robert S Fulton, Nancy L DiFronzo, Nancy Gillis, Mikkael A Sekeres, Matthew J Walter
Utility of Targeted Gene Sequencing to Differentiate Myeloid Malignancies from other Cytopenic Conditions. Blood advances (2023)
David A Sallman, Monzr M Al Malki, Adam S Asch, Eunice S Wang, Joseph G Jurcic, Terrence J Bradley, Ian W Flinn, Daniel A Pollyea, Suman Kambhampati, Tiffany N Tanaka, Joshua F Zeidner, Guillermo Garcia Manero, Deepa Jeyakumar, Rami S Komrokji, Jeffrey Lancet, Hagop M Kantarjian, Lin Gu, Yajia Zhang, Anderson Tan, Mark Chao, Carol O'Hear, Giridharan Ramsingh, Indu Lal, Paresh Vyas, Naval G Daver
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Mark Gurney, Abhishek A Mangaonkar, Terra Lasho, Christy Finke, Aref A Al-Kali, Naseema Gangat, Mithun Vinod Shah, Hassan B Alkhateeb, Ayalew Tefferi, David A Sallman, Zhuoer Xie, David Viswanatha, Kaaren Reichard, Najla Al Ali, Rami S Komrokji, Eric Padron, Mirinal S Patnaik
Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML). Leukemia (2023)
Barbara Mora, Margherita Maffioli, Elisa Rumi, Paola Guglielmelli, Marianna Caramella, Andrew T Kuykendall, Francesca Palandri, Alessandra Iurlo, Valerio De Stefano, Jean-Jacques Kiladjian, Elena M Elli, Nicola Polverelli, Jason Gotlib, Francesco Albano, Richard T Silver, Giulia Benevolo, David M Ross, Timothy Devos, Oscar Borsani, Tiziano Barbui, Matteo G Della Porta, Lorenza Bertù, Rami S Komrokji, Alessandro M Vannucchi, Francesco Passamonti
Incidence of blast phase in myelofibrosis according to anemia severity. EJHaem 4 (3) (2023)
Luis E Aguirre, Najla Al Ali, David A Sallman, Somedeb Ball, Akriti G Jain, Onyee Chan, Sara M Tinsley-Vance, Andrew Kuykendall, Kendra Sweet, Jeffrey E Lancet, Eric Padron, Rami S Komrokji
Assessment and validation of the molecular international prognostic scoring system for myelodysplastic syndromes. Leukemia (2023)
David A Sallman, Monzr M Al Malki, Adam S Asch, Eunice S Wang, Joseph G Jurcic, Terrence J Bradley, Ian W Flinn, Daniel A Pollyea, Suman Kambhampati, Tiffany N Tanaka, Joshua F Zeidner, Guillermo Garcia Manero, Deepa Jeyakumar, Rami S Komrokji, Jeffrey Lancet, Hagop M Kantarjian, Lin Gu, Yajia Zhang, Anderson Tan, Mark Chao, Carol O'Hear, Giridharan Ramsingh, Indu Lal, Paresh Vyas, Naval G Daver
Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Naseema Gangat, Andrew T Kuykendall, Najla H Al Ali, Swati Goel, Maymona Abdelmagid, Aref A Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek A Mangaonkar, Mark R Litzow, William Joseph Hogan, Mithun Vinod Shah, Mirinal S Patnaik, Animesh D Pardanani, Rami S Komrokji, Ayalew Tefferi
Black African-American patients with primary myelofibrosis: a comparative analysis of phenotype and survival. Blood advances (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Julian A Waksal, Claudia Bruedigam, Rami S Komrokji, Catriona H M Jamieson, John O Mascarenhas
Telomerase-Targeted Therapies in Myeloid Malignancies. Blood advances (2023)
Christopher T Letson, Maria E Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose, Markus Ball, Traci Kruer, Ariel Quintana, Terra L Lasho, Christy M Finke, Luciana L Almada, Jennifer Margaret Grants, Guolin Zhang, Martin E Fernandez-Zapico, Alexandre Gaspar-Maia, Jeffrey E Lancet, Rami S Komrokji, Eric B Haura, David A Sallman, Gary W Reuther, Aly Karsan, Uwe Rix, Mirinal S Patnaik, Eric Padron
Targeting BET proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Uwe Platzbecker, Valeria Santini, Rami S Komrokji, Amer M Zeidan, Guillermo Garcia Manero, Rena Buckstein, Dimana Miteva, Karen Keeperman, Natalia Holot, Jose Alberto Nadal, Yinzhi Lai, Sadanand Vodala, Barbara Rosettani, Ana Carolina Giuseppi, Aylin Yucel, Pierre Fenaux
Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts. Leukemia (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Farah Fleti, Onyee Chan, Amritpal Singh, Maymona G Abdelmagid, Aref A Al-Kali, Michelle A Elliott, Kebede H Begna, James M Foran, Talha Badar, Nandita Khera, Najla H Al Ali, Eric Padron, David A Sallman, Mithun Vinod Shah, Devendra K Hiwase, Animesh D Pardanani, Daniel A Arber, Attilio Orazi, Kaaren K Reichard, Rong He, Rhett P Ketterling, Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases. American journal of hematology 98 (4) (2023)
Mirinal S Patnaik, Amer M Zeidan, Eric Padron, Uwe Platzbecker, David A Sallman, Amy E DeZern, Rafael Bejar, Mikkael A Sekeres, Justin Taylor, Richard F Little, Jan P Bewersdorf, Tae Kon Kim, Nina Kim, Christopher S Hourigan, Matteo G Dela Porta, Maximilian Stahl, David Steensma, Mina L Xu, Olatoyosi Odenike, Hetty E Carraway, Pierre Fenaux, Aziz Nazha, Rami S Komrokji, Sanam Loghavi, Zhuoer Xie, Robert P Hasserjian, Michael R Savona, John M Bennett
Differences in classification schemata for myelodysplastic/myeloproliferative overlap neoplasms. Leukemia 36 (12) (2022)
Marie Robin, Liesbeth C de Wreede, Eric Padron, Katerina Bakunina, Pierre Fenaux, Linda Koster, Aziz Nazha, Dietrich W Beelen, Raajit K Rampal, Katja Sockel, Rami S Komrokji, Nico Gagelmann, Dirk-Jan Eikema, Aleksandar Radujkovic, Juergen Finke, Victoria Potter, Sally B Killick, Faezeh Legrand, Eric Solary, Angus Broom, Guillermo Garcia-Manero, Vittorio Rizzoli, Patrick Hayden, Mirinal S Patnaik, Francesco Onida, Ibrahim Yakoub Agha, Raphaël A Itzykson
Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis. Blood 140 (12) (2022)
Rami S Komrokji, Luis E Aguirre, Najla Al-Ali, Mohammad O Hussaini, David A Sallman, Dana E Rollison, Eric Padron
U2AF1 and EZH2 mutations are associated with nonimmune hemolytic anemia in myelodysplastic syndromes. Blood advances (2022)
Virginia O Volpe, Najla Al Ali, Onyee Chan, Eric Padron, David A Sallman, Andrew T Kuykendall, Kendra Sweet, Jeffrey E Lancet, Rami S Komrokji
Splicing factor 3B subunit 1 (SF3B1) mutation in the context of therapy-related myelodysplastic syndromes. British journal of haematology 198 (4) (2022)
Abhishek A Mangaonkar, Terra L Lasho, Rhett P Ketterling, Kaaren K Reichard, Naseema Gangat, Aref A Al-Kali, Kebede H Begna, Animesh Pardanani, Najla H Al Ali, Chetasi Talati, David A Sallman, Eric Padron, Mirinal S Patnaik, Ayalew Tefferi, Rami S Komrokji
Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients. Blood cancer journal 12 (2) (2022)
Rami S Komrokji, Avani M Singh, Najla Al Ali, Onyee Chan, Eric Padron, Kendra Sweet, Andrew Kuykendall, Jeffrey E Lancet, David A Sallman
Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome. Blood cancer journal 12 (11) (2022)
Rami S Komrokji, Uwe Platzbecker, Pierre Fenaux, Amer M Zeidan, Guillermo Garcia Manero, Ghulam J Mufti, Valeria Santini, Maria Diez Campelo, Carlo Finelli, Joseph G Jurcic, Peter L Greenberg, Mikkael A Sekeres, Amy E DeZern, Michael R Savona, Jeevan K Shetty, Rodrigo Ito, George Zhang, Xianwei Ha, Jay T Backstrom, Amit Verma
Luspatercept for myelodysplastic syndromes/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis. Leukemia 36 (5) (2022)
Claire N Harrison, Jacqueline S Garcia, Tim C P Somervaille, James M Foran, Srdan Verstovsek, Catriona Jamieson, Ruben A Mesa, Ellen K Ritchie, Srinivas K Tantravahi, Pankit Vachhani, Casey L O'Connell, Rami S Komrokji, Jason Harb, Jessica E Hutti, Leanne Holes, Abdullah A Masud, Silpa Nuthalapati, Jalaja Potluri, Naveen Pemmaraju
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (15) (2022)
Connor Walsh, Anthony Hunter, Terra Lasho, Christy Finke, Rhett Ketterling, Rami S Komrokji, Ayalew Tefferi, Abhishek A Mangaonkar, Matthew Howard, Naseema Gangat, Aref Al-Kali, Najla Al Ali, Eric Padron, Mirinal S Patnaik
Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia. Leukemia 36 (6) (2022)
Somedeb Ball, Akriti G Jain, Luis E Aguirre, Najla Al Ali, Yumeng Zhang, Onyee Chan, Andrew T Kuykendall, Kendra L Sweet, Jeffrey E Lancet, David M Swoboda, Eric Padron, Rami S Komrokji, David A Sallman
Hypomethylating agent and venetoclax in patients with chronic myelomonocytic leukemia: Is the combination indeed better? American journal of hematology 97 (5) (2022)
Eric J Duncavage, Adam Bagg, Robert P Hasserjian, Courtney D D DiNardo, Lucy A Godley, Ilaria Iacobucci, Siddhartha Jaiswal, Luca Malcovati, Alessandro Maria Maria Vannucchi, Keyur Pravinchandra Patel, Daniel A Arber, Maria E Arcila, Rafael Bejar, Nancy Berliner, Michael J Borowitz, Susan Branford, Anna L Brown, Catherine A Cargo, Hartmut Döhner, Brunangelo Falini, Guillermo Garcia-Manero, Torsten Haferlach, Eva Hellström-Lindberg, Annette S Kim, Jeffery M Klco, Rami S Komrokji, Mignon Lee-Cheun Loh, Sanam Loghavi, Charles G Mullighan, Seishi Ogawa, Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David Morrall Ross, Michael R Savona, Akiko Shimamura, Radek C Skoda, Francisco Solé, Richard M Stone, Ayalew Tefferi, Matthew J Walter, David Wu, Benjamin L Ebert, Mario Cazzola
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia. Blood 140 (21) (2022)
Amer M Zeidan, Uwe Platzbecker, Guillermo Garcia-Manero, Mikkael A Sekeres, Pierre Fenaux, Amy E DeZern, Peter L Greenberg, Michael R Savona, Joseph G Jurcic, Amit K Verma, Ghulam J Mufti, Rena Buckstein, Valeria Santini, Jeevan K Shetty, Rodrigo Ito, Jennie Zhang, George Zhang, Xianwei Ha, Jay T Backstrom, Rami S Komrokji
Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts. Blood 140 (20) (2022)
Margherita Maffioli, Barbara Mora, Somedeb Ball, Alessandra Iurlo, Elena Maria Elli, Maria Chiara Finazzi, Nicola Polverelli, Elisa Rumi, Marianna Caramella, Maria Cristina Carraro, Mariella D'Adda, Alfredo Molteni, Cinzia Sissa, Francesca Lunghi, Alessandro Vismara, Marta Ubezio, Anna Guidetti, Sabrina Caberlon, Michela Anghilieri, Rami S Komrokji, Daniele Cattaneo, Matteo Giovanni Della Porta, Toni Giorgino, Lorenza Bertù, Marco Brociner, Andrew T Kuykendall, Francesco Passamonti
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis. Blood advances 6 (6) (2022)
Andrew M Brunner, Alexander Gavralidis, Najla Al Ali, Anthony Hunter, Rami S Komrokji, Amer Zeidan, David A Sallman
Evaluating complete remission with partial hematologic recovery (CRh) as a response criterion in myelodysplastic syndromes (MDS). Blood cancer journal 12 (11) (2022)
David M Swoboda, Rashmi Kanagal-Shamana, Andrew M Brunner, Thomas Cluzeau, Onyee Chan, Najla Al Ali, Guillermo Montalban-Bravo, Quinto J Gesiotto, Alexander Gavralidis, Anthony M Hunter, Jung-Hoon Lee, Andrew T Kuykendall, Chetasi Talati, Kendra L Sweet, Jeffrey E Lancet, Eric Padron, Mohammad Hussaini, Jinming Song, Guillermo Garcia Manero, Rami S Komrokji, David A Sallman
Marrow ring sideroblasts are highly predictive for TP53 mutation in MDS with excess blasts. Leukemia 36 (4) (2022)
Amer M Zeidan, Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A Sekeres, David P Steensma, Uwe Platzbecker, Sanam Loghavi, Jacqueline Boultwood, Rafael Bejar, John M Bennett, Uma Borate, Andrew M Brunner, Hetty E Carraway, Jane E Churpek, Naval G Daver, Matteo Della Porta, Amy E DeZern, Fabio Efficace, Pierre Fenaux, Maria E Figueroa, Peter Greenberg, Elizabeth A Griffiths, Stephanie Halene, Robert P Hasserjian, Christopher S Hourigan, Nina Kim, Tae Kon Kim, Rami S Komrokji, Vijay Kutchroo, Alan F List, Richard F Little, Ravindra Majeti, Aziz Nazha, Stephen D Nimer, Olatoyosi Odenike, Eric Padron, Mirinal S Patnaik, Gail J Roboz, David A Sallman, Guillermo F Sanz, Maximilian Stahl, Daniel T Starczynowski, Justin Taylor, Zhuoer Xie, Mina L Xu, Michael R Savona, Andrew H Wei, Omar Abdel-Wahab, Valeria Santini
Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes. Leukemia 36 (12) (2022)
Barbara Mora, Paola Guglielmelli, Andrew Kuykendall, Elisa Rumi, Margherita Maffioli, Francesca Palandri, Valerio De Stefano, Marianna Caramella, Silvia Salmoiraghi, Jean-Jacques Kiladjian, Jason Gotlib, Alessandra Iurlo, Francisco Cervantes, Marco Ruggeri, Richard T Silver, Francesco Albano, Giulia Benevolo, David Morrall Ross, Matteo G Della Porta, Timothy Devos, Giada Rotunno, Rami S Komrokji, Ilaria C Casetti, Michele Merli, Marco Brociner, Domenica Caramazza, Giuseppe Auteri, Tiziano Barbui, Daniele Cattaneo, Lorenza Bertù, Luca Arcaini, Alessandro M Vannucchi, Francesco Passamonti
Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients. Leukemia 36 (10) (2022)
Naseema Gangat, Rami S Komrokji, Ayalew Tefferi
Venetoclax and hypomethylating agent therapy in myelodysplastic syndromes: Big picture perspective. American journal of hematology (2022)
Meghan C Ferrall-Fairbanks, Abhishek Dhawan, Brian Johnson, Hannah Newman, Virginia O Volpe, Christopher T Letson, Markus Ball, Anthony M Hunter, Maria E Balasis, Traci Kruer, Nana Adjoa Ben-Crentsil, Jodi L Kroeger, Robert Balderas, Rami S Komrokji, David A Sallman, Jing Zhang, Rafael Bejar, Philipp M Altrock, Eric Padron
Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse Outcomes. Blood cancer discovery 3 (6) (2022)
Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei, Michael R Savona, Mina L Xu, Zhuoer Xie, Justin Taylor, Daniel T Starczynowski, Guillermo F Sanz, David A Sallman, Valeria Santini, Gail J Roboz, Mirinal S Patnaik, Eric Padron, Olatoyosi Odenike, Aziz Nazha, Stephen D Nimer, Ravindra Majeti, Richard F Little, Steven D Gore, Alan F List, Vijay Kuchroo, Rami S Komrokji, Tae Kon Kim, Nina Kim, Christopher S Hourigan, Robert P Hasserjian, Stephanie Halene, Elizabeth A Griffiths, Peter L Greenberg, Maria E Figueroa, Pierre Fenaux, Fabio Efficace, Amy E DeZern, Matteo G Della Porta, Naval G Daver, Jane E Churpek, Hetty E Carraway, Andrew M Brunner, Uma Borate, John M Bennett, Rafael Bejar, Jacqueline Boultwood, Sanam Loghavi, Jan Philipp Bewersdorf, Uwe Platzbecker, David P Steensma, Mikkael A Sekeres, Rena J Buckstein, Amer M Zeidan
An agenda to advance research in MDS: A TOP 10 Priority List from the first international workshop in MDS (iwMDS). Blood advances (2022)
Thomas Cluzeau, Marie Sebert, Ramy Rahmé, Stefania Cuzzubbo, Jacqueline Lehmann-Che, Isabelle Madelaine, Pierre Peterlin, Blandine Bève, Habiba Attalah, Fatiha Chermat, Elsa Miekoutima, Odile Beyne Rauzy, Christian Recher, Aspasia Stamatoullas, Lise Willems, Emmanuel Raffoux, Céline Berthon, Bruno Quesnel, Michael Loschi, Antoine F Carpentier, David A Sallman, Rami S Komrokji, Anouk Walter-Petrich, Sylvie Chevret, Lionel Ades, Pierre Fenaux
Eprenetapopt Plus Azacitidine in TP53-Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
David A Sallman, Amy E DeZern, Guillermo Garcia Manero, David P Steensma, Gail J Roboz, Mikkael A Sekeres, Thomas Cluzeau, Kendra L Sweet, Amy F McLemore, Kathy L McGraw, John Puskas, Ling Zhang, Jiqiang Yao, Qianxing Mo, Lisa Nardelli, Najla H Al Ali, Eric Padron, Greg Korbel, Eyal C Attar, Hagop M Kantarjian, Jeffrey E Lancet, Pierre Fenaux, Alan F List, Rami S Komrokji
Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
Alan F List, Zhuoxin Sun, Amit K Verma, John M Bennett, Rami S Komrokji, Kathy McGraw, Jaroslaw Maciejewski, Jessica K Altman, Puneet S Cheema, David F Claxton, Selina M Luger, Ryan J Mattison, Timothy R Wassenaar, Andrew S Artz, Charles A Schiffer, Mark R Litzow, Martin S Tallman
Lenalidomide-Epoetin Alfa Versus Lenalidomide Monotherapy in Myelodysplastic Syndromes Refractory to Recombinant Erythropoietin. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (9) (2021)
John O Mascarenhas, Rami S Komrokji, Francesca Palandri, Bruno Martino, Dietger Niederwieser, Andreas Reiter, Bart L Scott, Maria R Baer, Ronald Hoffman, Olatoyosi Odenike, Alessandro M Vannucchi, Jacqueline Bussolari, Eugene Zhu, Esther Rose, Laurie Sherman, Souria Dougherty, Libo Sun, Fei Huang, Ying Wan, Faye M Feller, Aleksandra Rizo, Jean-Jacques Kiladjian
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (26) (2021)
Rashmi Kanagal-Shamana, Guillermo Montalban-Bravo, Panagiotis Katsonis, Koji Sasaki, Caleb A Class, Elias Jabbour, David A Sallman, Anthony Michael Hunter, Christopher Benton, Kelly S Chien, Rajyalakshmi Luthra, Carlos E Bueso-Ramos, Tapan Mahendra Kadia, Michael Andreeff, Rami S Komrokji, Najla H Al Ali, Nicholas James Short, Naval G Daver, Mark J Routbort, Joseph D Khoury, Keyur Pravinchandra Patel, Irene Ganan-Gomez, Yue Wei, Gautam Borthakur, Farhad Ravandi, Kim-Anh Do, Kelly A Soltysiak, Olivier Lichtarge, L Jeffrey Medeiros, Hagop M Kantarjian, Guillermo Garcia Manero
Evolutionary action score identifies a subset of TP53 mutated myelodysplastic syndrome with favorable prognosis. Blood cancer journal 11 (3) (2021)
David P Steensma, Martin Wermke, Virginia M Klimek, Peter L Greenberg, Patricia Font, Rami S Komrokji, Jay Yang, Andrew M Brunner, Hetty E Carraway, Lionel Ades, Aref A Al-Kali, Juan M Alonso-Dominguez, Ana Alfonso-Piérola, Catherine C Coombs, H Joachim Deeg, Ian W Flinn, James M Foran, Guillermo Garcia Manero, Michael B Maris, Malgorzata McMasters, Jean-Baptiste Micol, Jaime Perez De Oteyza, Felicitas Thol, Eunice S Wang, Justin M Watts, Justin Taylor, Richard Stone, Vikram Gourineni, Alyssa J Marino, Huilan Yao, Benoit Destenaves, Xiaobin Yuan, Kun Yu, Sara Dar, Lernik Ohanjanian, Keisuke Kuida, Jianjun Xiao, Catherine Scholz, Antonio Gualberto, Uwe Platzbecker
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms. Leukemia 35 (12) (2021)
Aziz Nazha, Rami S Komrokji, Manja Meggendorfer, Xuefei Jia, Nathan Radakovich, Jacob Shreve, C Beau Hilton, Yasunubo Nagata, Betty K Hamilton, Sudipto Mukherjee, Najla Al Ali, Wencke Walter, Stephan Hutter, Eric Padron, David A Sallman, Teodora Kuzmanovic, Cassandra Kerr, Vera Adema, David P Steensma, Amy Dezern, Gail J Roboz, Guillermo Garcia Manero, Harry P Erba, Claudia Haferlach, Jaroslaw P Maciejewski, Torsten Haferlach, Mikkael A Sekeres
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic Syndromes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (33) (2021)
Akriti Gupta Jain, Ling Zhang, John M Bennett, Rami S Komrokji
Myelodysplastic Syndromes with Bone Marrow Fibrosis: An Update. Annals of laboratory medicine 42 (3) (2021)
Nathan Radakovich, Manja Meggendorfer, Luca Malcovati, C Beau Hilton, Mikkael A Sekeres, Jacob Shreve, Yazan Rouphail, Wencke Walter, Stephan Hutter, Anna Galli, Sara Pozzi, Chiara Elena, Eric Padron, Michael R Savona, Aaron T Gerds, Sudipto Mukherjee, Yasunobu Nagata, Rami S Komrokji, Babal Kant Jha, Claudia Haferlach, Jaroslaw P Maciejewski, Torsten Haferlach, Aziz Nazha
A geno-clinical decision model for the diagnosis of myelodysplastic syndromes. Blood advances 5 (21) (2021)
Onyee Chan, Rami S Komrokji
Luspatercept in the treatment of lower-risk myelodysplastic syndromes. Future oncology (London, England) 17 (12) (2021)
Guillermo Garcia-Manero, Ghulam J Mufti Obe, Pierre Fenaux, Rena J Buckstein, Valeria Santini, Maria Diez Campelo, Carlo Finelli, Osman Ilhan, Mikkael A Sekeres, Amer M Zeidan, Rodrigo Ito, Jennie Zhang, Anita Rampersad, Daniel Sinsimer, Jay T Backstrom, Uwe Platzbecker, Rami S Komrokji
Neutrophil and platelet increases with luspatercept in lower-risk MDS: secondary endpoints from the MEDALIST trial. Blood (2021)
Rami S Komrokji, Virginia Volpe, Onyee Chan, Najla Al Ali, David Swoboda, Andrew Kuykendall, Eric Padron, David M Swoboda
Validation of the international working group proposal for SF3B1 mutant myelodysplastic syndromes. Blood 138 (11) (2021)
Rami S Komrokji, Najla H Al Ali, David A Sallman, Eric Padron, Amy E DeZern, John Barnard, Gail J Roboz, Guillermo Garcia-Manero, Alan List, David P Steensma, Mikkael A Sekeres
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium. Cancer medicine 10 (2) (2020)
David M Swoboda, Najla Al Ali, Onyee Chan, Eric Padron, Andrew T Kuykendall, Jinming Song, Mohammad Hussaini, Chetasi Talati, Kendra Sweet, Jeffrey E Lancet, David A Sallman, Rami S Komrokji
PTPN11 mutations are associated with poor outcomes across myeloid malignancies. Leukemia 35 (1) (2020)
Rami S Komrokji, Najla Al Ali, David Sallman, Eric Padron, Jeffrey E Lancet, Lubomir Sokol, Christa Varnadoe, P K Burnette, Alan List
Characterization of myelodysplastic syndromes (MDS) with T-cell large granular lymphocyte proliferations (LGL). Leukemia 34 (11) (2020)
Seongseok Yun, Susan M Geyer, Rami S Komrokji, Najla H Al Ali, Jinming Song, Mohammad Hussaini, Kendra L Sweet, Jeffrey E Lancet, Alan F List, Eric Padron, David A Sallman
Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML). Leukemia 35 (4) (2020)
Andrew T Kuykendall, Chetasi Talati, Eric Padron, Kendra L Sweet, Jeffrey E Lancet, Alan F List, David A Sallman, Rami S Komrokji
Driver mutation-specific clinical and genomic correlates differ between primary and secondary myelofibrosis. American journal of hematology 94 (12) (2019)
Barbara Mora, Elisa Rumi, Paola Guglielmelli, Daniela Barraco, Margherita Maffioli, Alessandro Rambaldi, Marianna Caramella, Rami S Komrokji, Jason Gotlib, Jean Jacques Kiladjian, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T Silver, Giulia Benevolo, Francesco Albano, Chiara Cavalloni, Daniela Pietra, Tiziano Barbui, Giada Rotunno, Mario Cazzola, Alessandro Maria Vannucchi, Toni Giorgino, Francesco Passamonti
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients. Cancer medicine 8 (9) (2019)
Barbara Mora, Paola Guglielmelli, Elisa Rumi, Margherita Maffioli, Daniela Barraco, Alessandro Rambaldi, Marianna Caramella, Rami S Komrokji, Jean-Jacques Kiladjian, Jason Gotlib, Alessandra Iurlo, Francisco Cervantes, Timothy Devos, Francesca Palandri, Valerio De Stefano, Marco Ruggeri, Richard T Silver, Francesco Albano, Giulia Benevolo, Chiara Cavalloni, Silvia Uccella, Raffaella Accetta, Claudia Siracusa, Stefania Agnoli, Michele Merli, Tiziano Barbui, Lorenza Bertù, Mario Cazzola, Alessandro Maria Maria Vannucchi, Francesco Passamonti
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. American journal of hematology 95 (1) (2019)
Christopher B Benton, Maliha Khan, David Sallman, Aziz Nazha, Graciela M Nogueras González, Jin Piao, Jing Ning, Fleur Aung, Najla Al Ali, Elias J Jabbour, Tapan Mahendra Kadia, Gautam Borthakur, Farhad Ravandi, Sherry Pierce, David Steensma, Amy DeZern, Gail Roboz, Mikkael Sekeres, Michael Andreeff, Hagop M Kantarjian, Rami S Komrokji, Guillermo Garcia-Manero
Prognosis of patients with intermediate risk IPSS-R myelodysplastic syndrome indicates variable outcomes and need for models beyond IPSS-R. American journal of hematology 93 (10) (2018)
Andrew T Kuykendall, Chetasi Talati, Eric Padron, Kendra L Sweet, David Sallman, Alan F List, Jeffrey E Lancet, Rami S Komrokji
Genetically inspired prognostic scoring system (GIPSS) outperforms dynamic international prognostic scoring system (DIPSS) in myelofibrosis patients. American journal of hematology 94 (1) (2018)
Rami S Komrokji, John F Seymour, Andrew W Roberts, Martha Wadleigh, L Bik To, Robyn Scherber, Elyce Turba, Andrew Dorr, Joy Zhu, Lixia Wang, Tanya Granston, Mary S Campbell, Ruben A Mesa
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis. Blood 125 (17) (2015)